ARSA (Search Result) Help

Search Result

Facet

Division

now loading

    Organism_facet

    now loading

      List of Entries

      1 - entries / Number of founds: 134  
        PrimaryAccessionNumber Definition SequenceLength MolecularType Organism
      MT694613 Miniopterus fuliginosus isolate N20110 D-loop, partial sequence; mitochondrial. 294 DNA Miniopterus fuliginosus
      N20110 yx29b01.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:263113 3' similar to gb:M64241 QM PROTEIN (HUMAN);contains Alu repetitive element, mRNA sequence. 251 mRNA Homo sapiens
      DJ149490 JP 2007228956-A/20108: Method for identification of useful proteins derived from brewery yeast. 25 DNA Saccharomyces pastorianus
      HV876651 JP 2010507387-A/20062: Novel siRNAs and Methods of Use Thereof. 21 RNA synthetic construct
      LZ207187 JP 2017148060-A/20110: OLIGONUCLEOTIDE MODULATORS OF THE TOLL-LIKE RECEPTOR PATHWAY. 18 RNA synthetic construct
      DM721255 JP 2016500250-A/20110: ENGINEERED SECRETED PROTEINS AND METHODS. 659 PRT Escherichia coli
      DL901854 JP 2014205669-A/20110: Method of constructing and screening libraries of peptide structures. 22 PRT synthetic construct
      DL610712 JP 2011092200-A/20110: NEISSERIAL ANTIGENIC PEPTIDES. 5 PRT Neisseria
      LV565932 JP 2017029159-A/20110: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS. 40 DNA synthetic construct
      PA390833 JP 2021533803-A/19916: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE. 26 DNA Homo sapiens
      DM756804 JP 2014079248-A/20110: NEISSERIAL ANTIGENIC PEPTIDES. 5 PRT Neisseria
      OG656496 JP 2021500321-A/20110: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES. 189 PRT synthetic construct
      HZ524891 JP 2016501039-A/20110: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS. 40 DNA synthetic construct
      MD752352 JP 2019507579-A/20110: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY. 20 DNA synthetic construct
      DD546713 JP 2004508801-A/20110: NEISSERIAL ANTIGENIC PEPTIDES. 5 PRT Neisseria
      MC903848 JP 2018536623-A/20110: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF. 37 PRT synthetic construct
      MC772220 JP 2018525446-A/20110: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF. 31 PRT synthetic construct
      MC161954 JP 2019500349-A/20110: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES. 18 RNA synthetic construct
      HW567175 JP 2014509511-A/20110: OLIGONUCLEOTIDE MODULATORS OF THE TOLL-LIKE RECEPTOR PATHWAY. 18 RNA synthetic construct
      HW855334 JP 2015051004-A/20062: Novel siRNA's and Use Thereof. 21 RNA synthetic construct
      PA524594 JP 2022502046-A/7376: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY. 21 DNA synthetic construct
      DJ523910 JP 2010517930-A/20110: Method of constructing and screening libraries of peptide structures. 22 PRT synthetic construct
      MB762271 JP 2018535655-A/26168: ASGR INHIBITORS. 9 PRT synthetic construct
      MD266243 JP 2020517247-A/20110: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof. 20 DNA synthetic construct
      DL029124 JP 2005512499-A/20110: Diagnosis of existing illnesses or that praedisposition for determined illnesses. 1079 DNA synthetic construct
      PA335758 JP 2021522188-A/20110: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation. 20 DNA synthetic construct
      MB809368 JP 2019502674-A/20110: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF. 40 PRT synthetic construct
      DM794568 JP 2014068652-A/20110: NEISSERIAL ANTIGENIC PEPTIDES. 5 PRT Neisseria
      OG749629 JP 2021120380-A/20110: CANCER NEOEPITOPES. 9 PRT Homo sapiens
      LX117726 JP 2017506877-A/20108: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes. 16 DNA synthetic construct
      Now loading
      PAGE TOP